Showing results (1221-1230 of 1,416) with videos related to
Sort By:
Pageof 142
Circulation. Cardiovascular Quality and Outcomes|February 4, 2010
Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarctionDennis T Ko, Joseph S Ross, Yongfei Wang, et al.Circulation. Cardiovascular Quality and Outcomes|April 8, 2010
Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA)Khurram Nasir, Robyn L McClelland, Roger S Blumenthal, et al.Circulation. Cardiovascular Quality and Outcomes|April 8, 2010
Socioeconomic position, not race, is linked to death after cardiac surgeryColleen G Koch, Liang Li, George A Kaplan, et al.Circulation. Cardiovascular Quality and Outcomes|April 15, 2010
Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) TrialJ Aaron Grantham, Philip G Jones, Louis Cannon, et al.Circulation. Cardiovascular Quality and Outcomes|May 21, 2010
Developing an instrument to measure heart failure disease management program intensity and complexityBarbara Riegel, Christopher S Lee, Julie SochalskiCirculation. Cardiovascular Quality and Outcomes|May 22, 2010
Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patientsThomas M Maddox, Colleen Ross, Heather M Tavel, et al.Circulation. Cardiovascular Quality and Outcomes|May 22, 2010
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarctionAdam C Salisbury, Karen P Alexander, Kimberly J Reid, et al.Circulation. Cardiovascular Quality and Outcomes|July 29, 2010
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?Bernard R Chaitman, Pamela M Hartigan, David C Booth, et al.Circulation. Cardiovascular Quality and Outcomes|April 1, 2010
Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery systemP Michael Ho, Thomas T Tsai, Tracy Y Wang, et al.Circulation. Cardiovascular Quality and Outcomes|June 17, 2010
Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul studyJames V Pottala, Sachin Garg, Beth E Cohen, et al.Pageof 142